SecBot SecBot
SECBOTREPLAY Home › Report › TAK

TAK · Takeda filed its annual Corporate Governance Report, confirming…

TAKEDA PHARMACEUTICAL CO LTD · 6-K filed Jul 9, 2026 at 06:00 ET

At the news

NEUTRALIMPACT 2/10

6-K filed Jul 9, 2026 at 06:00 ET

Takeda filed its annual Corporate Governance Report, confirming compliance with all principles of the Corporate Governance Code. The report details board composition (8 of 11 directors are independent external directors, chair is independent), board effectiveness evaluation, and director compensation policy. No material financial or operational updates were disclosed.

  • Company in full compliance with all Corporate Governance Code principles
  • Board comprises 11 directors; 8 are independent external directors (majority); board chair is an independent external director
  • No anti-takeover measures adopted; no parent company or major shareholder above 10%
  • Board effectiveness evaluation concluded the BOD is operating effectively, noting a transition period with CEO succession and director offboarding

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access